Wednesday, December 3
- 12:00 PM – 01:00 PM: REGISTRATION AND COFFEE
- 01:00 PM – 01:15 PM: OPENING REMARKS
Gerald Batist, MD. Member of the McGill Centre for Translational Research and Associate Director of the Axe Experimental Therapies RRCancer.
- 01:15 PM – 02:40 PM: PANEL DISCUSSION 1 - THE VOICE OF THE PATIENT
Chair: Karine-Iseult Ippersiel, President and CEO of the Quebec Breast Cancer Foundation
Talk 1: Value Over Volume: Patient-Centered Approaches to Molecular Testing in Quebec Oncology
Eva Villalba, MBA, MSc. Executive Director, Quebec Cancer Coalition
Talk 2: When Genomics Gets Personal: A Scientist and Breast Cancer Patient Perspective
Catalina Lopez-Correa, PhD. Chief Global Strategy Officer at Genome Canada
Talk 3: Transforming Patient Care Through the Pragmatic Trials Collaboratory in Real-world Practice
Nathalie Tremblay, PhD, Co-Founder and Board Director at C4Care – Consortium international de santé
Discussion and Q&A
- 02:40 PM – 03:10 PM: COFFEE BREAK
- 03:10 PM – 04:45 PM: PANEL DISCUSSION 2 - BEYOND GENOMICS: THE ADVANCES OF MOLECULAR PROFILING
Chair: Philippe Lefrançois, MD. Assistant Professor at the Department of Medicine, McGill University
Talk 1: Clinical and Translational Proteomics: Providing Decision-Making Information in Medicine
Christoph Borchers, PhD. Director of Segal Cancer Proteomics Centre and Full Professor at the Department of Oncology, McGill University
Talk 2: Modulating Immunotherapy Outcomes Through Fecal Microbiota Transplantation: Impacts on Response and Toxicity
Saman Maleki, PhD. Associate Professor at the Department of Oncology, Western University
Talk 3: Advancing Microbiome-Based Cancer Therapies: From Bench-to-Bedside
Edmond Rafie, MD. Clinician-scientist Fellow at the CHUM Microbiome Centre, Centre hospitalier de l’Université de Montréal (CRCHUM).
Talk 4 (Trainee Presentation): miRNA Biomarkers Predicting Gemcitabine-docetaxel Response in Leiomyosarcoma
Pegah Rahimizadeh, PhD Candidate, RI-MUHC, McGill University
Discussion and Q&A
- 04:45 PM –06:45 PM: NETWORKING COCKTAIL AND POSTER EXHIBITION
Thursday, December 4
- 07:30 AM – 03:30 PM: REGISTRATION AND COFFEE
- 08:00 AM – 09:50 AM: PANEL DISCUSSION 3 - D2R: SHOWCASING RNA THERAPEUTIC APPLICATIONS
Chair: Michael Witcher, PhD. Assistant Professor at the Department of Oncology, McGill University
Talk 1: The Jerry Pelletier Initiative: Diagnostic and Therapeutic Innovations for Rare Cancers
Yasser Riazalhosseini, PhD. Head of the Cancer Genomics program at the McGill University Genome Centre; Associate Professor at the Department of Human Genetics, McGill University
Talk 2: Re-Heating the Immune-Cold Pancreas: Cancer Vaccines to Reprogram Pancreatic Tumor Immunity
Kim Ma, MD. Assistant Professor at the Department of Oncology, McGill University
Talk 3: Rise of the vaccine trials: concept and practicality in lung and bladder cancer.
Ramy Saleh, MD, MSc. Associate Professor at the Department of Oncology, McGill University
Talk 4 (Trainee Presentation): CRC Unplugged: Tracing NFE2L3 From Gut Microbiota to Colitis and Cancer
Anantpreet Kaur Sood, PhD Candidate, Lady Davis Institute, McGill University
Discussion and Q&A
- 09:50 AM – 10:20 AM: COMPLIMENTARY BREAKFAST & COFFEE BREAK
- 10:20 AM – 11:45 AM: PANEL DISCUSSION 4 - ADVANCES AND APPLICATIONS IN LIQUID BIOPSIES
Chair: Mark Basik, MD. Professor, Departments of Surgery and Oncology, McGill University
Talk 1: Advances In Liquid Biopsies at The Jewish General Hospital
Adriana Aguliar, PhD. Scientific Director of the Cancer Genomics and Translational Research Laboratory
Talk 2: Whole genome sequencing as a uniting force for cancer detection, diagnostics, and monitoring
Trevor Pugh, PhD. Director of Genomics Program & Senior Investigator, Ontario Institute for Cancer Research; Professor at Department of Medical Biophysics, University of Toronto
Talk 3 (Trainee Presentation): Development of a Second-Generation Diagnostic Test Based on Ganglioside Biomarkers for Early Detection of Ovarian Cancer
Migmar Tsamchoe, PhD. Post-Doc Fellow, Lady Davis Institute, McGill University
Discussion and Q&A
- 11:45 AM – 12:45 PM: LUNCH BREAK
- 12:45 PM – 01:45 PM: POSTER EXHIBITION AND EVALUATION
- 01:45 PM – 03:10 PM: PANEL DISCUSSION 5 - AI IN CANCER PREDICTION AND TREATMENT
Chair: John Kildea, PhD. Associate Professor at the Department of Oncology, McGill University
Talk 1: Building Digital Pathology AI Models for Cancer Detection and Prediction.
Anne Martel, PhD, Senior Scientist at Sunnybrook Research Institute; Professor at the Department of Medical Biophysics, University of Toront
Talk 2: Integrative topic modeling analysis of transcriptomes and pathology images
Yue Li, PhD, Associate Professor at the School of Computer Science, McGill University
Talk 3 (Trainee Presentation): Association of Deep Learning-Derived Paraspinal Muscle Sarcopenia with Mortality in Head and Neck Cancer
Joshua Ron Onichino, Medical Student and Machine learning Intern, Lady Davis Institute, McGill University
Discussion and Q&A
- 03:10 PM – 03:40 PM: COFFEE BREAK
- 03:40 PM – 05:05 PM: PANEL DISCUSSION 6 - TRANSLATING DISCOVERIES INTO CLINICAL PRACTICE
Chair: Miriam Santos Dutra, PhD. Chief Operating Officer of McGill Centre of Translational Research in Cancer at the Jewish General Hospital
Talk 1: The Translational Challenge: From Pipette to Patient
Denis Claude Roy, MD. Chief Scientific Officer of the C3i Centre; Chief Executive Officer at CellCAN, and Full Professor of Medicine, University of Montreal
Talk 2: From PhD to co-founder of a medical device company - Why I would do it again
Francois Therriault-Proulx, PhD, Chief Executive Officer & Co-Founder at MedScint
Talk 3: Accelerating Translation: AI-driven models and Consortium Approaches
Armstrong Murira, PhD, Co-Founder and CEO at Simmunome
Discussion and Q&A
- 05:05 PM – 05:30 PM: AWARD CEREMONY & CLOSING REMARKS
Gerald Batist, MD. Member of the McGill Centre for Translational Research and Associate Director of the Axe Experimental Therapies RRCancer.
